Evidence map›Paper›PMID 40416015›Full record

ReviewJMA journal2025

Retracted: Chronic Epipharyngitis Treated with Epipharyngeal Abrasion Therapy: Symptoms, Diagnosis, Pathogenesis, and Treatment Outcomes.

Yasuaki Harabuchi, Takumi Kumai, Kensuke Nishi, Ayaki Tanaka, Osamu Hotta, Hitoshi Hagino, Toshiyuki Kusuyama, Manabu Mogitate, Yoshihiro Ohno, Akira Sakakibara and 10 more

RetractedAbstract readReviewRetracted Publication
In one paragraph

Review in JMA journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

20 authors.

Yasuaki HarabuchiEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Takumi KumaiEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Kensuke NishiEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Ayaki TanakaEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Osamu HottaEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Hitoshi HaginoEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Toshiyuki KusuyamaEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Manabu MogitateEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Yoshihiro OhnoEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Akira SakakibaraEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Satsuki ArakiEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Yoshinao NishidaEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Tomoko ShintaniEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Hiroyuki TakezawaEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Hirofumi ItoEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Daigo KomazawaEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Noriko NishiwakiEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Ryuzo ToritaniEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Koichi HirahataEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.
Satoshi MarumoEpipharyngeal Abrasion Therapy Review Committee, Japan Society of Stomato-pharyngology, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic epipharyngitis is associated with a wide variety of symptoms, including local symptoms such as postnasal drip, sore throat, lump sensation of the pharynx, headache, chronic cough, nasal obstruction, tinnitus/ear fullness, chronic phlegm and dysphonia due to inflammation of the epipharynx, functional somatic symptoms such as chronic fatigue, dizziness, insomnia, brain fog, abdominal discomfort, and depression caused by dysfunction of the hypothalamus-limbic system via disturbances of vagal response and cerebrospinal fluid outflow, and distant organ symptoms such as immunoglobulin A nephropathy and palmoplantar pustulosis caused by the epipharyngeal lymphoid tissue as an etiologic organ. In the past, chronic inflammation in the epipharynx was difficult to prove by gross findings, now, direct observation of the epipharyngeal inflammation by endoscopy has become easier for the diagnosis. For the treatment of chronic epipharyngitis, epipharyngeal abrasive therapy (EAT), epipharyngeal application of a 1% zinc chloride solution intranasally or orally was popular since the 1960s, recently, endoscopic EAT (E-EAT), in which epipharynx is safely and accurately observed and abraded under clear vision using an endoscope, has been developed. The mechanisms of EAT effects can be classified into anti-inflammatory/antiviral effect, bloodletting effect, and vagus nerve stimulation effect. Recently, the effectiveness of EAT for post-acute sequelae of coronavirus disease 2019 (COVID-19), known as long COVID, has come into the limelight, and the number of patients for whom EAT is expected to increase. In 2019, the Japan Society of Stomato-pharyngology established the EAT Review Committee to accumulate evidence on the efficacy of EAT and to establish indications and techniques for its use. In this article, the EAT Review Committee outlines its symptoms, pathogenesis, and diagnosis of chronic epipharyngitis, technique of E-EAT, mechanisms of EAT effects, past reports for the efficacy of EAT, and a multicenter prospective study.

Indexed as

chronic epipharyngitisepipharyngeal abrasive therapy (EAT)IgA nephropathylong COVIDmyalgia encephalomyelitis/chronic fatigue syndromepalmoplantar pustulosisvagus nerve stimulation autoimmune/inflammatory syndrome induced by adjuvants (ASIA)

Identifiers

PMID40416015
PMCPMC12095231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.